GGrantIndex
← Search

IGF::OT::IGF: DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT FOR NIDA (DSC4). N01DA-14-2237. PERIOD OF PERFORMANCE: JUNE 19, 2014 TO JUNE 18, 2019.

$3,582,979N01FY2016DANIH

The Emmes Company, Llc, Rockville MD

Investigators

Abstract

The Contractor shall provide resources to support NIDA in its goal of conducting clinical trials to test the effectiveness of new science-based drug abuse treatments in community settings. The clinical trials performed will be Phase I, Phase II, and Phase III/IV medication trials and/or stage I/II and stage III behavior therapy trials. The studies will be carried out in multiple sites across the country in a variety of treatment settings. Activities will support the trials carried out under cooperative agreements, grants or other funding mechanisms and expert consultation in clinical research.

View original record on NIH RePORTER →